Akshay S Desai Selected Research

Angiotensin Receptor Antagonists

12/2021	Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON-HF.
12/2021	Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF Trial.
1/2021	Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF.
5/2018	Incident Hyperkalemia, Hypokalemia, and Clinical Outcomes During Spironolactone Treatment of Heart Failure With Preserved Ejection Fraction: Analysis of the TOPCAT Trial.
4/2018	Sacubitril/Valsartan: From Clinical Trials to Real-world Experience.
11/2017	Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.
5/2017	The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Trial.
1/2017	Treatment of Hyperkalemia in Heart Failure.
4/2016	Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trial.
12/2009	Hyperkalemia in patients with heart failure: incidence, prevalence, and management.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akshay S Desai Research Topics

Disease

224	Heart Failure 05/2024 - 08/2006
24	Cardiomyopathies (Cardiomyopathy) 05/2024 - 12/2004
19	Chronic Renal Insufficiency 04/2024 - 12/2009
16	Type 2 Diabetes Mellitus (MODY) 05/2024 - 10/2011
14	Hyperkalemia 10/2019 - 11/2007
13	Atrial Fibrillation 05/2024 - 01/2018
12	Heart Diseases (Heart Disease) 05/2024 - 12/2014
12	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 12/2012
12	Stroke (Strokes) 01/2023 - 12/2012
10	Hypotension (Low Blood Pressure) 03/2024 - 12/2012
10	Myocardial Infarction 03/2024 - 12/2004
9	Heart Arrest (Cardiac Arrest) 01/2022 - 12/2012
9	Diabetes Mellitus 01/2022 - 11/2015
8	Chronic Obstructive Pulmonary Disease (COPD) 01/2024 - 12/2017
8	Sudden Death 01/2024 - 12/2004
8	Anemia 01/2023 - 10/2011
6	Hypokalemia 01/2019 - 09/2013
5	Hypertension (High Blood Pressure) 01/2024 - 12/2014
5	Frailty 10/2023 - 01/2018
4	Systolic Heart Failure 04/2022 - 03/2013
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 12/2012
4	Chronic Kidney Failure (Chronic Renal Failure) 04/2016 - 11/2011
3	COVID-19 09/2023 - 09/2020
3	Edema (Dropsy) 01/2023 - 01/2019
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 10/2020 - 12/2004
3	Respiratory Sounds (Crackle) 01/2019 - 09/2013
3	Albuminuria 11/2018 - 09/2011
3	Fibrosis (Cirrhosis) 05/2017 - 01/2010
2	Kidney Diseases (Kidney Disease) 04/2024 - 01/2023
2	Dyspnea (Shortness of Breath) 01/2024 - 01/2023
2	Inflammation (Inflammations) 01/2024 - 01/2020
2	Hypovolemia 12/2023 - 10/2020
2	Obesity 01/2023 - 11/2022
2	Peripheral Arterial Disease 01/2023 - 01/2011
2	Weight Loss (Weight Reduction) 11/2022 - 01/2016
2	Human Influenza (Influenza) 01/2021 - 02/2016
2	Death (Near-Death Experience) 12/2019 - 01/2018
2	Angioedema 10/2019 - 09/2014
2	Atherosclerosis 06/2019 - 01/2019

Drug/Important Bio-Agent (IBA)

54	sacubitril and valsartan sodium hydrate drug combinationIBA 04/2024 - 07/2014
52	dapagliflozinIBA 05/2024 - 01/2019
39	Mineralocorticoid Receptor AntagonistsIBA 05/2024 - 12/2009
32	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2024 - 09/2011
30	Neprilysin (Neutral Endopeptidase)IBA 01/2023 - 09/2013
29	Enalapril FDA LinkGeneric 03/2024 - 07/2014
24	Natriuretic PeptidesIBA 05/2024 - 01/2013
24	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2023 - 09/2013
23	Spironolactone (Aldactone)FDA LinkGeneric 05/2024 - 11/2007
23	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023 - 11/2007
21	pro-brain natriuretic peptide (1-76)IBA 05/2024 - 09/2011
18	CreatinineIBA 04/2024 - 11/2007
17	paragonIBA 03/2024 - 01/2017
15	DiureticsIBA 05/2024 - 06/2008
14	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2011
12	PotassiumIBA 01/2023 - 11/2007
11	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 01/2011
11	Sodium-Glucose Transport ProteinsIBA 05/2024 - 01/2019
11	SodiumIBA 02/2024 - 12/2017
11	aliskiren FDA Link 01/2023 - 02/2012
10	Angiotensin Receptor AntagonistsIBA 12/2021 - 12/2009
9	Valsartan (Vals)FDA Link 03/2024 - 01/2017
8	Irbesartan FDA LinkGeneric 01/2023 - 03/2010
8	Darbepoetin alfa (Aranesp)FDA Link 04/2022 - 10/2011
8	candesartanIBA 08/2021 - 11/2007
7	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2023 - 11/2019
7	AngiotensinsIBA 07/2023 - 09/2014
6	Hemoglobins (Hemoglobin)IBA 01/2023 - 03/2013
5	Insulin (Novolin)FDA Link 01/2023 - 01/2011
4	AlbuminsIBA 04/2024 - 09/2011
4	Influenza Vaccines (Influenza Vaccine)FDA Link 11/2023 - 02/2016
4	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2023 - 01/2019
4	Troponin T (Troponin T1)IBA 01/2022 - 10/2011
4	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2016 - 09/2013
3	Antihypertensive Agents (Antihypertensives)IBA 01/2024 - 12/2014
3	Peptides (Polypeptides)IBA 07/2023 - 01/2020
3	TroponinIBA 01/2023 - 01/2018
3	Uric Acid (Urate)IBA 01/2023 - 01/2018
2	Eplerenone (Inspra)FDA LinkGeneric 05/2024 - 11/2015
2	finerenoneIBA 05/2024 - 05/2024
2	C-Reactive ProteinIBA 01/2024 - 10/2011
2	Urea (Carbamide)FDA LinkGeneric 12/2023 - 12/2017
2	NitrogenIBA 12/2023 - 12/2017
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 01/2022
2	Furosemide (Lasix)FDA LinkGeneric 01/2023 - 01/2018
2	Therapeutic UsesIBA 01/2023 - 01/2022
2	AnticoagulantsIBA 11/2022 - 11/2017
2	ReninIBA 01/2021 - 02/2012
2	Thyroid HormonesIBA 06/2019 - 01/2019
2	Trinitrotoluene (TNT)IBA 01/2019 - 11/2011

Therapy/Procedure

76	Therapeutics 05/2024 - 12/2004
7	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022 - 12/2004
5	Palliative Care (Palliative Therapy) 10/2023 - 01/2018
5	Patient Readmission 10/2022 - 08/2003
4	Defibrillators (Defibrillator) 01/2022 - 12/2004
3	Transplantation 09/2015 - 11/2012
2	Polypharmacy 04/2024 - 11/2021
2	Drug Therapy (Chemotherapy) 01/2023 - 06/2017
2	Surgical Amputation (Amputations) 01/2023 - 01/2023
2	Cardiac Resynchronization Therapy 01/2022 - 01/2020
2	Drug Tapering 01/2019 - 11/2007